SK279399B6 - Cyklický peptid, spôsob jeho výroby a farmaceutick - Google Patents

Cyklický peptid, spôsob jeho výroby a farmaceutick Download PDF

Info

Publication number
SK279399B6
SK279399B6 SK3086-92A SK308692A SK279399B6 SK 279399 B6 SK279399 B6 SK 279399B6 SK 308692 A SK308692 A SK 308692A SK 279399 B6 SK279399 B6 SK 279399B6
Authority
SK
Slovakia
Prior art keywords
lys
asp
ala
seq
boc
Prior art date
Application number
SK3086-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK308692A3 (en
Inventor
David R. Bolin
Margaret O'donnell
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SK308692A3 publication Critical patent/SK308692A3/sk
Publication of SK279399B6 publication Critical patent/SK279399B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK3086-92A 1991-10-11 1992-10-09 Cyklický peptid, spôsob jeho výroby a farmaceutick SK279399B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (2)

Publication Number Publication Date
SK308692A3 SK308692A3 (en) 1995-03-08
SK279399B6 true SK279399B6 (sk) 1998-11-04

Family

ID=25099195

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3086-92A SK279399B6 (sk) 1991-10-11 1992-10-09 Cyklický peptid, spôsob jeho výroby a farmaceutick

Country Status (26)

Country Link
US (1) US5677419A (fi)
EP (1) EP0536741B1 (fi)
JP (1) JP2515473B2 (fi)
KR (1) KR970001580B1 (fi)
CN (3) CN1034943C (fi)
AT (1) ATE132165T1 (fi)
AU (1) AU656230B2 (fi)
BG (1) BG61125B2 (fi)
BR (1) BR9203959A (fi)
CA (1) CA2080272C (fi)
CZ (1) CZ281818B6 (fi)
DE (1) DE69207138T2 (fi)
DK (1) DK0536741T3 (fi)
ES (1) ES2082317T3 (fi)
FI (2) FI111646B (fi)
GR (1) GR3019326T3 (fi)
HU (2) HUT62606A (fi)
IL (3) IL117252A (fi)
MX (1) MX9205822A (fi)
NO (3) NO304523B1 (fi)
NZ (1) NZ244644A (fi)
RU (1) RU2095368C1 (fi)
SK (1) SK279399B6 (fi)
TW (1) TW305846B (fi)
UY (2) UY23488A1 (fi)
ZA (1) ZA927724B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
DE69735991D1 (de) * 1996-02-09 2006-07-06 Hoffmann La Roche Herstellung eines vip-analogen
WO1998002192A1 (en) * 1996-07-12 1998-01-22 Immunomedics, Inc. Radiometal-binding peptide analogues
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
SK5552002A3 (en) * 1999-09-28 2003-05-02 Bayer Ag Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
EP1257575B1 (en) 2000-02-18 2007-02-28 Dabur Research Foundation Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
EP1257576B1 (en) * 2000-02-18 2004-09-15 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
CA2428552A1 (en) 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
DE60326723D1 (de) 2002-06-10 2009-04-30 Mondobiotech Licensing Out Ag Verwendung von zusammensetzungen mit der biologischen aktivität der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
KR20070009554A (ko) * 2004-01-27 2007-01-18 바이엘 파마슈티칼스 코포레이션 뇌하수체 아데닐레이트 사이클라제 활성화 펩티드(ｐａｃａｐ) 수용체 (ｖｐａｃ２) 작용제 및 이의약리학적 사용 방법
EP1781692A2 (en) * 2004-08-18 2007-05-09 Eli Lilly And Company Selective vpac2 receptor peptide agonists
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
CN101389647A (zh) * 2006-02-28 2009-03-18 伊莱利利公司 选择性vpac2受体肽激动剂
EP2041168A2 (en) * 2006-07-06 2009-04-01 F.Hoffmann-La Roche Ag Novel analogs of vasoactive intestinal peptide
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
JP5801807B2 (ja) 2009-08-14 2015-10-28 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド 修飾された血管作動性腸管ペプチド
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9561262B2 (en) 2011-06-06 2017-02-07 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
JP6824888B2 (ja) 2015-02-09 2021-02-03 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド 筋肉の疾患および障害を治療するための方法および組成物
KR102243870B1 (ko) 2016-09-30 2021-04-22 후지필름 가부시키가이샤 환상 펩타이드, 어피니티 크로마토그래피 담체, 표지화 항체, 항체 약물 복합체 및 의약 제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
BG61125B2 (bg) 1996-11-29
HU211534A9 (en) 1995-12-28
FI20002041A (fi) 2000-09-15
TW305846B (fi) 1997-05-21
US5677419A (en) 1997-10-14
UY25084A1 (es) 1998-12-21
NZ244644A (en) 1995-04-27
CN1152579A (zh) 1997-06-25
NO975023D0 (no) 1997-10-31
ES2082317T3 (es) 1996-03-16
NO980377D0 (no) 1998-01-28
KR930007972A (ko) 1993-05-20
KR970001580B1 (ko) 1997-02-11
FI111646B (fi) 2003-08-29
IL117252A0 (en) 1996-06-18
FI924580A0 (fi) 1992-10-09
CA2080272A1 (en) 1993-04-12
DK0536741T3 (da) 1996-04-22
SK308692A3 (en) 1995-03-08
EP0536741A2 (en) 1993-04-14
AU2622892A (en) 1993-04-22
CN1225473C (zh) 2005-11-02
HU9203194D0 (en) 1992-12-28
CN1034943C (zh) 1997-05-21
ZA927724B (en) 1994-04-07
CN1198841C (zh) 2005-04-27
IL117252A (en) 1999-11-30
CZ281818B6 (cs) 1997-02-12
AU656230B2 (en) 1995-01-27
DE69207138T2 (de) 1996-06-13
EP0536741A3 (fi) 1994-04-06
NO923929L (no) 1993-04-13
BR9203959A (pt) 1993-04-27
ATE132165T1 (de) 1996-01-15
NO304523B1 (no) 1999-01-04
NO980377L (no) 1993-04-13
HUT62606A (en) 1993-05-28
CN1072415A (zh) 1993-05-26
GR3019326T3 (en) 1996-06-30
RU2095368C1 (ru) 1997-11-10
CZ308692A3 (en) 1993-08-11
NO923929D0 (no) 1992-10-09
EP0536741B1 (en) 1995-12-27
DE69207138D1 (de) 1996-02-08
UY23488A1 (es) 1993-04-20
NO975023L (no) 1993-04-13
IL103396A (en) 1997-11-20
MX9205822A (es) 1993-06-01
FI924580A (fi) 1993-04-12
CN1153785A (zh) 1997-07-09
JPH05213996A (ja) 1993-08-24
JP2515473B2 (ja) 1996-07-10
CA2080272C (en) 2002-09-17
IL103396A0 (en) 1993-03-15

Similar Documents

Publication Publication Date Title
SK279399B6 (sk) Cyklický peptid, spôsob jeho výroby a farmaceutick
US4605641A (en) Synthetic vasoactive intestinal peptide analogs
FI88402B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara grf-analoger
US5583108A (en) Vasonatrin peptide and analogs thereof
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
SK88893A3 (en) Novel amylin antagonist peptides and uses therefor
WO1990003980A1 (en) Therapeutic peptides
US4734400A (en) Synthetic vasoactive intestinal peptide analogs
US5141924A (en) Synthetic vasoactive intestinal peptide analogs
AU6751290A (en) Synthetic calcitonin peptides
EP0363589A2 (en) Somatostatin analogues
KR100629013B1 (ko) Ｉｇｆ-ⅰ 및 -ⅱ를 억제하는 ｇｈ-ｒｈ의 길항 유사체
US5234907A (en) Synthetic vasoactive intestinal peptide analogs
AU8237187A (en) Derivatives of atrial natriuretic peptides
WO1989010935A1 (en) Atrial peptide derivatives
IE53488B1 (en) Crf and analogues
EP0307860B1 (en) Cyclic GRF-analogs
FI111647B (fi) Menetelmä terapeuttisesti käyttökelpoisten syklisten peptidien valmistamiseksi
US5013721A (en) Anorexigenic and hypotensive peptides
US5502164A (en) Peptide compounds having therapeutic activity